These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26950274)

  • 1. Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
    Vieillard V; Gharakhanian S; Lucar O; Katlama C; Launay O; Autran B; Ho Tsong Fang R; Crouzet J; Murphy RL; Debré P
    Oncotarget; 2016 Jun; 7(25):38946-38958. PubMed ID: 26950274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifarious immunotherapeutic approaches to cure HIV-1 infection.
    Imami N; Herasimtschuk AA
    Hum Vaccin Immunother; 2015; 11(9):2287-93. PubMed ID: 26048144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
    Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
    J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Immune Interventions for an HIV-1 Cure.
    Perreau M; Banga R; Pantaleo G
    Trends Mol Med; 2017 Oct; 23(10):945-961. PubMed ID: 28890135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unexpected journey: how cancer immunotherapy has paved the way for an HIV-1 cure.
    Smith KN; Housseau F
    Discov Med; 2015 Mar; 19(104):229-38. PubMed ID: 25828527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplified antigen-specific immune responses in HIV-1 infected individuals in a double blind DNA immunization and therapy interruption trial.
    Gudmundsdotter L; Wahren B; Haller BK; Boberg A; Edbäck U; Bernasconi D; Buttò S; Gaines H; Imami N; Gotch F; Lori F; Lisziewicz J; Sandström E; Hejdeman B
    Vaccine; 2011 Jul; 29(33):5558-66. PubMed ID: 21300092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies".
    Cafaro A; Sgadari C; Picconi O; Tripiciano A; Moretti S; Francavilla V; Pavone Cossut MR; Buttò S; Cozzone G; Ensoli F; Monini P; Ensoli B
    Expert Rev Vaccines; 2018 Feb; 17(2):115-126. PubMed ID: 29243498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly neutralizing antibodies: An approach to control HIV-1 infection.
    Yaseen MM; Yaseen MM; Alqudah MA
    Int Rev Immunol; 2017 Jan; 36(1):31-40. PubMed ID: 27739924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly Neutralizing Antibodies for HIV Eradication.
    Stephenson KE; Barouch DH
    Curr HIV/AIDS Rep; 2016 Feb; 13(1):31-7. PubMed ID: 26841901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding HIV infection for the design of a therapeutic vaccine. Part II: Vaccination strategies for HIV.
    de Goede AL; Vulto AG; Osterhaus AD; Gruters RA
    Ann Pharm Fr; 2015 May; 73(3):169-79. PubMed ID: 25528627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection.
    Herasimtschuk A; Downey J; Nelson M; Moyle G; Mandalia S; Sikut R; Adojaan M; Stanescu I; Gotch F; Imami N
    Vaccine; 2014 Dec; 32(51):7005-7013. PubMed ID: 25454870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction.
    Yang H; Wallace Z; Dorrell L
    Front Immunol; 2018; 9():2861. PubMed ID: 30564246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
    Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
    J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV immunotherapy comes of age: implications for prevention, treatment and cure.
    Routy JP; Mehraj V; Cao W
    Expert Rev Clin Immunol; 2016; 12(2):91-4. PubMed ID: 26629806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?
    Vanham G; Van Gulck E
    Retrovirology; 2012 Sep; 9():72. PubMed ID: 22958464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine and immunotherapeutic interventions.
    Pantaleo G; Lévy Y
    Curr Opin HIV AIDS; 2013 May; 8(3):236-42. PubMed ID: 23478912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
    Sung JA; Pickeral J; Liu L; Stanfield-Oakley SA; Lam CY; Garrido C; Pollara J; LaBranche C; Bonsignori M; Moody MA; Yang Y; Parks R; Archin N; Allard B; Kirchherr J; Kuruc JD; Gay CL; Cohen MS; Ochsenbauer C; Soderberg K; Liao HX; Montefiori D; Moore P; Johnson S; Koenig S; Haynes BF; Nordstrom JL; Margolis DM; Ferrari G
    J Clin Invest; 2015 Nov; 125(11):4077-90. PubMed ID: 26413868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.
    Euler Z; Alter G
    AIDS Res Hum Retroviruses; 2015 Jan; 31(1):13-24. PubMed ID: 25385703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trispecific broadly neutralizing antibodies for HIV immunoprophylaxis and immunotherapy?].
    Barin F; Stefic K
    Med Sci (Paris); 2018 Feb; 34(2):109-111. PubMed ID: 29451475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.